BGI Genomics released its performance for the first three quarters, with a net loss attributable to the parent company of 21.387 million yuan
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, BGI Genomics released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 2.674 billion yuan, a year-on-year decrease of 5.39%. The net loss attributable to shareholders of the listed company was 21.387 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.7647 million yuan
According to the Zhitong Finance APP, BGI Genomics (300676.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 2.674 billion yuan, a year-on-year decrease of 5.39%. The net loss attributable to shareholders of the listed company was 21.387 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 66.7647 million yuan